Search Results 1701-1710 of 21334 for anti-TNF drugs

1. A Trial to Evaluate the Effectiveness, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... treatment with more than 1 oral PAH-approved therapy or any parenteral therapy. ... anti-fibrotic drug within 4 ...

2. Levofloxacin (Oral Route) Proper Use - Mayo Clinic

   This medicine comes with a Medication Guide. Read and follow the instructions carefully. Ask your doctor if you have any questions.

3. Levofloxacin (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

4. Low-phosphorus diet: Helpful for kidney disease? - Mayo Clinic

   Your doctor may also recommend a phosphate binder medication to help control the amount of phosphorus your body absorbs from foods. These medications only help ...

5. A Study to Evaluate Tazemetostat Combined with Lenalidomide Plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health Letter · Healthy Lifestyle. Featured conditions. Brain tumor, breast cancer ...

6. Rituximab (Intravenous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

7. Diabetic Retinopathy Clinical Trials - Mayo Clinic Research

   Intravitreous anti-vascular endothelial growth factor (anti-VEGF) therapy alone or vitrectomy combined with intraoperative PRP each provide the opportunity ...

8. A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy - Mayo Clinic

   ... treatment in spite of adequate anti-infective therapy; Autologous or allogeneic bone marrow transplant as second-line therapy. Pregnant or lactating females ...

9. GEN3013, Epcoritamab Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma EPCORE™ NHL-1 - Mayo Clinic

   ... therapy including at least 1 anti-CD20 monoclonal antibodycontaining therapy. Note: Relapsed disease is defined as disease that has recurred ≥ 6 months ...

10. New breast cancer drug is 'very exciting'

    "While the primary goal of the study was to safely deliver therapeutic levels of endoxifen, one of the most surprising observations was the prolonged anti ...